The table below consolidates the most recent comparable data on hospital bed density for Morocco, Tunisia, Egypt, Turkey, and Saudi Arabia. Most figures draw on World Bank compilations of national health ministry reporting, supplemented by OECD data for Turkey. Because countries report in different years, the "latest available" column reflects the most recent data point accessible as of mid-2025; we note the reference year for transparency.

Sources and caveats: Morocco's private bed count (15,500+) is sourced from verified industry data. Saudi Arabia's national average of 2.43 beds per 1,000 is drawn from a recent national analysis that noted this figure falls below the global average of 2.9. Egypt's figure is based on World Bank 2021 data. Turkey's data benefits from OECD reporting, which provides granular ICU breakdowns; the OECD's Health at a Glance 2025 notes that since 2013, beds per capita have decreased in nearly all OECD countries, with an average of 17 ICU beds per 100,000 across 31 OECD members. Turkey's ICU capacity, at roughly 28 to 30 per 100,000, substantially exceeds this OECD average, reflecting its massive city hospital construction program. Tunisia and Morocco ICU estimates are indicative, derived from partial ministry disclosures and academic literature rather than a single authoritative source; they should be treated with appropriate caution.

Key observations from the data:

Morocco sits at the bottom of this five-country peer group on overall bed density, roughly half the level of Tunisia and less than 40% of Turkey's ratio. The gap is even more pronounced for ICU capacity, where Turkey and Saudi Arabia operate at five to eight times Morocco's estimated per-capita level. Egypt, despite a larger population and significant fiscal pressures, has managed a modestly higher bed ratio than Morocco, partly through a wave of public hospital construction in new administrative cities. Tunisia, with a smaller population and a more mature public health infrastructure inherited from decades of social spending, maintains a ratio roughly double Morocco's.

The 2020 to 2024 period saw modest improvements across most markets, driven largely by COVID-19 response investments. Morocco expanded field hospital capacity during the pandemic and accelerated plans for regional hospital centers (CHUs), but the structural bed deficit has not been materially closed. Turkey's trajectory is the most aggressive, with its integrated city hospital model adding tens of thousands of beds in purpose-built mega-facilities since 2018.

Several factors explain Morocco's position at the lower end of regional bed density rankings. First, historical public health spending as a share of GDP has been comparatively low. While the Kingdom has increased health budgets in recent years, particularly following the generalization of social protection (AMO) launched in 2021, capital expenditure on physical infrastructure takes years to translate into operational beds. Second, geographic concentration is a persistent issue: the private sector's 15,500+ beds are overwhelmingly located in two regions, leaving rural and semi-urban areas underserved. Third, workforce constraints compound the infrastructure gap; Morocco's physician density (roughly 7 per 10,000 population) limits the effective utilization of any new beds added.

Turkey's outperformance is largely a function of its public-private partnership (PPP) city hospital program, which has delivered over 30,000 new beds since 2017 through build-operate-transfer models. Saudi Arabia's Vision 2030 health pillar has channeled significant sovereign wealth into hospital construction and private-sector licensing, pushing bed density toward the global average. Egypt's approach has been more state-led, with large public hospital projects in the New Administrative Capital and Upper Egypt, though private sector participation is growing. Tunisia's relative stability reflects a mature but fiscally constrained system with limited new capacity additions.

ICU capacity deserves separate attention. The COVID-19 pandemic exposed critical shortages across North Africa. Morocco's estimated 3 to 4 ICU beds per 100,000 population is far below the OECD average of 17 per 100,000 and dramatically below Turkey and Saudi Arabia. This gap represents both a public health vulnerability and a commercial opportunity, as ICU beds carry higher revenue per bed-day and require specialized equipment and staffing that create barriers to entry.

Morocco's structural bed deficit, combined with the ongoing rollout of universal health coverage under AMO, creates a multi-year investment thesis for healthcare infrastructure. The expansion of insured populations directly increases effective demand for hospital services, while the supply side remains constrained. This demand-supply imbalance is most acute in secondary cities and specialized care segments such as ICU, oncology, and cardiac surgery.

For private equity and institutional investors, several entry points merit evaluation. First, greenfield private clinic development outside the Casablanca-Rabat corridor addresses both the geographic maldistribution of beds and the growing purchasing power of newly insured populations in cities like Marrakech, Tangier, Fez, and Agadir. Second, medical device and equipment suppliers stand to benefit from any capacity expansion; Morocco's medical device market is already subject to a structured registration regime, and suppliers with local distribution capabilities are well-positioned. Third, PPP models for hospital construction, similar to Turkey's city hospital program, are under active discussion in Morocco, and investors with experience in healthcare PPPs in the MENA region may find a receptive policy environment.

Saudi Arabia and Turkey offer instructive precedents. Turkey's PPP city hospitals have attracted international construction and facilities management firms, while Saudi Arabia's privatization of government hospitals under Vision 2030 has opened opportunities for hospital management companies. Morocco's trajectory is earlier-stage, which implies higher execution risk but also less competition and potentially more favorable entry valuations.

Investors should also monitor regulatory developments. Morocco's health ministry has signaled intentions to reform hospital licensing and accreditation standards, which could raise compliance costs but also improve the quality premium that well-capitalized operators can command. For a deeper assessment of market entry mechanics and regulatory navigation, Smart.by's Market Entry and Business Setup advisory provides structured support for healthcare sector entrants.